BRIEF published on 04/18/2025 at 18:05, 11 months ago ABIVAX: Share Capital and Voting Rights as of March 31, 2025 Euronext Paris Share Capital Voting Rights Actions Abivax
BRIEF published on 04/18/2025 at 18:05, 11 months ago ABIVAX: Details of Share Capital and Voting Rights as of March 31, 2025 Euronext Paris Share Capital Voting Rights Biotechnology Abivax
BRIEF published on 03/27/2025 at 18:05, 11 months 22 days ago ABIVAX: Update of share capital and voting rights Share Capital Voting Rights Biotechnology AMF Abivax
BRIEF published on 03/26/2025 at 22:10, 11 months 23 days ago Abivax publishes its 2024 financial reports Biotechnology AMF Abivax Financial Reports DRY
PRESS RELEASE published on 03/26/2025 at 22:05, 11 months 23 days ago Abivax publishes financial reports with the French and U.S. securities regulatory agencies Abivax publishes financial reports with French and U.S. securities regulatory agencies. The company filed its Universal Registration Document and Annual Report for 2024 Abivax Financial Reports Regulatory Agencies U.S. Securities French
BRIEF published on 03/24/2025 at 08:35, 11 months 26 days ago Abivax Publishes its Financial Results for 2024 Financial Results Biotechnology Research And Development Treasury Clinical Trials
PRESS RELEASE published on 03/24/2025 at 08:30, 11 months 26 days ago Abivax Announces Full Year 2024 Financial Results Abivax announces full year 2024 financial results, cash balance of EUR 144.2M, ABTECT trial progress. CEO optimistic about 2025 milestones and financial outlook Financial Results Cash Position Abivax ABTECT Trial Clinical Progress
BRIEF published on 03/14/2025 at 15:21, 1 year ago JP Morgan Chase Reduces Stake in ABIVAX Actions Abivax Regulation Threshold Crossing JP Morgan Chase
BRIEF published on 03/13/2025 at 12:43, 1 year ago JP Morgan Crosses Threshold in ABIVAX Voting Rights Actions Abivax Threshold Crossing JP Morgan
BRIEF published on 02/25/2025 at 18:05, 1 year ago ABIVAX: Information on capital and voting rights as of January 31, 2025 Euronext Paris Share Capital Voting Rights Abivax Finances
Published on 03/19/2026 at 12:00, 20 minutes ago Galway Metals Intersects 8.6 g/t Gold Over 15.0m Including 110.0 g/t Over 1.0m at Southwest Deposit
Published on 03/19/2026 at 12:00, 20 minutes ago Gamma Resources Announces Debt Settlement and Insider Warrant Exercises
Published on 03/19/2026 at 12:00, 20 minutes ago Prince Silver Delivers Further Strong Drill Results, Highlighted by 7.62 Metres of 230 G/T Silver, 10.78% Manganese, 1.87% Lead, 2.54% Zinc and 0.58 G/T Gold
Published on 03/19/2026 at 12:00, 20 minutes ago Athena Gold Provides Exploration Update From Excelsior Springs, Nevada
Published on 03/19/2026 at 12:00, 20 minutes ago Aclara Inaugurates Rare Earth Separation Pilot Plant in Virginia Tech to Advance U.S. Supply of Heavy Rare Earths
Published on 03/19/2026 at 12:10, 10 minutes ago ZPMC Completes First Emissions Rights Transaction in Shanghai
Published on 03/19/2026 at 12:05, 15 minutes ago CD&R Expands Climate Leadership Program to Europe with Imperial College Business School and Extends Columbia University Partnership in the U.S. for Second Year
Published on 03/19/2026 at 12:00, 20 minutes ago PT Danantara Investment Management opens DPT registration for PSEL partners
Published on 03/19/2026 at 08:45, 3 hours 35 minutes ago Deezer and Sonos renew and expand long-term collaboration
Published on 03/19/2026 at 07:00, 5 hours 20 minutes ago bioMérieux Receives IVDR CE‑Marking for Two BIOFIRE® SPOTFIRE® Panels to Strengthen Near‑Patient Respiratory and Sore Throat Diagnostics Across Europe
Published on 03/19/2026 at 07:00, 5 hours 20 minutes ago 2025 Annual results and new strategic signature
Published on 03/18/2026 at 19:41, 16 hours 39 minutes ago Covivio - Conditions of availability of the 2025 Universal Registration Document
Published on 03/18/2026 at 18:00, 18 hours 20 minutes ago Deezer achieves profitability in FY25 as strategy delivers tangible results
